Pfizer drug Xalkori effective against rare lung cancer in clinical trial

Pfizer's Xalkori drug was found to be effective against non-small-lung cancer patients with ROS1 gene abnormalities. The medicine decreased the size of tumors in 36 out of 50 patients with the rare disease.